Gain- and loss-of-function experiments uncover that FBXW2 overexpression suppresses proliferation, stemness, migratory capacity, and invasive potential in human GC cells and tumor xenografts, while silencing of FBXW2 yield the opposite results. The gene discussed is FBXW2; the disease is neoplasm.